Molecular-docking of some Amines and Furane Derivatives with IRAK-4 Using a Theoretical Model
Open Access
- 15 June 2026
- journal article
- Published by AMG Transcend Association in Biointerface Research in Applied Chemistry
- Vol. 16 (3)
Abstract
For several years, some IRAK-4 inhibitors have been developed to treat chronic lymphocytic leukemia; however, their interaction with the IRAK-4 kinase is unclear. The aim of this study was to evaluate the interaction of some amine and furanone derivatives with IRAK-4 as a therapeutic alternative to treat chronic lymphocytic leukemia. The theoretical coupling of amine and furanone derivatives with the IRAK-4 was carried out using the 5uit protein as a theoretical model. Besides, 1-439 PF-3758309, 336113-53-2, 509093-47-4, ND-2158, and emavusertib drugs were used as controls in the DockingServer program. The results displayed different types of amino acid residues involved in the interaction of amine and furanone derivatives with the 5uit protein surface compared to the controls. Besides, the inhibition constant was lower for amino derivatives 3, 9, 25, 33, and 36 compared with the controls. Other data indicate that the inhibition constant was lower for furanone analogs 1, 3, 7, 13, 27, 32, and 34 compared with PF-3758309, 336113-53-2, 509093-47-4, ND-2158, and emavusertib. In conclusion, theoretical data indicate that amine (3, 9, 25, 33, and 36) and furanones (1, 3, 7, 13, 27, 32, and 34) derivatives might have a higher affinity for the 5uit protein surface compared with the controls. This data suggests that both amino and furanone derivatives can act as IRAK-4 inhibitors, which may serve to treat chronic lymphocytic leukemia.Keywords
This publication has 49 references indexed in Scilit:
- Establishment of a Vancomycin Population Pharmacokinetic Model for Pediatric Patients Based on the Non-Linear Mixed-Effects ModelDrugs in R&D, 2025
- Halogenated Curcumin Derivatives: SwissADME/ADMT, DFT and Biological Targets PredictionChemistry Africa, 2025
- Chronic Lymphocytic Leukemia: 2025 Update on the Epidemiology, Pathogenesis, Diagnosis, and TherapyAmerican Journal of Hematology, 2025
- Construction of IRAK4 inhibitor activity prediction model based on machine learningMolecular Diversity, 2024
- The recent advance of Interleukin-1 receptor associated kinase 4 inhibitors for the treatment of inflammation and related diseasesEuropean Journal of Medicinal Chemistry, 2023
- IRAK family in inflammatory autoimmune diseasesAutoimmunity Reviews, 2020
- Discovery of potent IRAK-4 inhibitors as potential anti-inflammatory and anticancer agents using structure-based exploration of IRAK-4 pharmacophoric space coupled with QSAR analysesComputational Biology and Chemistry, 2019
- A new approach for accurate prediction of toxicity of amino compoundsJournal of the Iranian Chemical Society, 2014
- Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy functionJournal of Computational Chemistry, 1998
- Merck molecular force field. I. Basis, form, scope, parameterization, and performance of MMFF94Journal of Computational Chemistry, 1996